Nanoviricides (NNVC) closed at $1.42 on November 10, 2026, up 6.8% from the previous close, on volume of 201,169 shares (30-day average 230,747).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
An Investigational Drug to Tackle Measles Outbreaks
ACCESS Newswire (Tue, 10-Nov 8:45 AM ET)
ACCESS Newswire (Tue, 27-Oct 9:15 AM ET)
ACCESS Newswire (Tue, 20-Oct 8:45 AM ET)
ACCESS Newswire (Tue, 13-Oct 8:45 AM ET)
ACCESS Newswire (Tue, 6-Oct 8:45 AM ET)
ACCESS Newswire (Mon, 5-Oct 8:45 AM ET)
ACCESS Newswire (Tue, 29-Sep 8:45 AM ET)
ACCESS Newswire (Mon, 28-Sep 8:45 AM ET)
ACCESS Newswire (Wed, 23-Sep 8:30 AM ET)
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.
Nanoviricides trades on the AMEX stock market under the symbol NNVC.
As of November 10, 2026, NNVC stock price climbed to $1.42 with 201,169 million shares trading.
NNVC has a beta of 1.99, meaning it tends to be more sensitive to market movements. NNVC has a correlation of 0.08 to the broad based SPY ETF.
NNVC has a market cap of $36.25 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, NNVC traded as high as $3.59 and as low as $.85.
The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF, BUSM.
NNVC has underperformed the market in the last year with a return of -22.8%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NNVC shares. However, NNVC has outperformed the market in the last 3 month and 2 week periods, returning 0.0% and +4.4%, while SPY returned -2.8% and -2.0%, respectively. This indicates NNVC has been having a stronger performance recently.
NNVC support price is $1.26 and resistance is $1.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.
